So-Youn Kim, PhD - Lab

Active Grants

1. Oogenic JNK in gonadotoxic chemotherapy-induced primary ovarian insufficiency
   NIH/NICHD, R01
   9/01/2024-8/30/2029
   Xiao, Shuo (PI), Kim, So-Youn (MPI) 
2. Understanding the Protective Effect of VEGFA on Ovarian Vasculature Against Chemotherapy Toxicity
   NRI, Collaboration Initiative
   7/01/2024-6/30/2025
   Kim, So-Youn (PI), Cupp, Andrea (co-PI)

3. Activin A signaling in PDAC-driven cachexia
   Buffett Cancer Center 
   2/1/2024-1/31/2025 
   Kim, So-Youn (PI), Duan, Bin (Co-PI), Jianghu Dong (Co-I) 

4. A Novel Ex Vivo System for Long-Term Whole Ovary Culture 
   NIH (SBIR R43, Phase I) 
   9/23/2023-8/31/2024 
   Ting, Alison (PI), Kim, So-Youn (Co-I), McGinnis, Lynda (Co-I) 

5. Transforming gynecological drug delivery by exploiting ovarian homing peptides 
   White Fund for Medical Research 
   7/1/2023-6/30/2024 
   Harris, Lynda (PI), Kim, So-Youn (Co-PI), Josh Santarpia (Co-PI) 

6. PIP5K1A is a novel mutant KRAS effector and essential for pancreatic cancer cell survival 
   FPBCC at UNMC 
   2/1/2023-1/31/2024 
   Choi, Suyong (PI), Kim, So-Youn (Co-PI) 

7. Investigation of the Role of PPARg in Growth and Metabolism of Granulosa Cell Tumor 
   Granulosa Cell Tumor Research Foundation (GCTRF) 
   9/1/2022-8/31/2024 
   Kim, So-Youn (PI)

8. Development of mechanism-based ovarian reserve protecting adjuvant therapies against gonadotoxic therapeutic agents 
   NIH/NICHD, R01 (Grant No. 5R01HD096042-02) 
   9/09/2019-8/31/2024 
   Kim, So-Youn (PI)